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ABSTRACT 
 
The objective of the paper is to review and analyze the health of population and health care 
expenditure and to examine the trends of convergence of health care expenditure in EU countries. 
One of the most often used indicators characterizing a population’s health is life expectancy at 
birth. Comparative analyses show that the life expectancy at birth in EU-12 countries is much 
lower than in EU-15 countries. Although in 1992-2004 the life expectancy increased both in EU-
15 countries and in EU-12 countries, the differences in the life expectancy have still remained 
more or less the same. Besides the low life expectancy in EU-12 countries, also the resources used 
in health care are below the EU-15 average level. In our paper we test the β-, σ- and γ-
convergence of the health care expenditure. For testing β-, σ- and γ-convergence the authors have 
used cross-sectional data over the period 1992-2004 for health care expenditure as share of GDP 
and per capita health care expenditure. Data of the World Health Organization (WHO) were used 
for the research. The study demonstrates that although usually the increase of economic 
integration facilitates economic growth, the mere fact of the European Union enlargement does 
not bring along an automatic homogenization of health care expenditure and health policy in the 
EU-12 countries. 
 
 
1.  INTRODUCTION 
 
everal economic growth theories treat human capital as the principal factor of economic growth. The 
quality of human capital depends not only on the educational level of population, but also on health. The 
population’s health situation is affected by various social and economic factors, but also by health policy 
and the resources used in health care. Macroeconomic evidence confirms that countries with the weakest conditions 
of health and education have much harder time achieving a sustained growth than countries with better conditions of 
health and education (Macroeconomics and Health, 2001). The state of health of the employees has an equally 
important role. The better health may increase output not only through labor productivity but also through the 
accumulation of capital (see Bils and Klenow, 2000; Bloom et al., 2001). Analyses of the inter-relationships 
between health and economic productivity can be conducted at the level of individuals, at regional levels within a 
country, and for aggregate data on countries (Bhargava et al., 2001). There are numerous studies on the relationship 
between health and economic growth (see, for example, Alsan et al., 2006; Jamison et al., 2004; Bloom et al., 2003; 
Macroeconomics and Health, 2001; Kalemi-Ozcan et al., 2000; etc.). 
 
Bloom, Canning and Sevilla (2001) added into their model of economic growth in addition to other 
parameters also average life expectancy and found that health has a positive and statistically significant effect on 
economic growth. “It suggests that one-year improvement in life expectancy contributes to an increase of 4 percent 
in output. This is a relatively large effect indicating that increased expenditures improving health might be justified 
purely on the ground of their impact on labor productivity” (ibid, p. 20). Bhargava, Jamison and Murray (2001) 
found that the 5-year growth rate of per capita GDP depends among other factors also on the mortality rate of adults. 
Alsan, Bloom Canning (2006) discovered that a one-year improvement in life expectancy is associated with an 9% 
increase in gross FDI inflow to low- and middle-income countries. 
 
S 
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Campos and Coricelli (2002) have analyzed the economic growth of transition economies and showed that 
the early years of the transition witnessed a rapid increase in mortality rates, and a major explanatory factor for these 
is the increase in adult male mortality (Campos and Coricelli, 2002). According to Sala-i-Martin, Doppelhofer and 
Miller (2004), human capital and health (life expectancy) are one of the main factors of long-term economic growth.  
 
A substantial part of the literature is examining the convergence across countries over time (Barro, 1991; 
Mankiw et al., 1992; Barro and Sala-i-Martin, 1992; Sala-i-Martin, 1996, DeLong, 1988, etc.). Also, there have been 
a large number of studies confirming the importance of human capital. Several studies have presented evidence of 
the convergence, using measures of education (O’Neill, 1995; Cohen, 1996). Nixon (1999) analyzed the health care 
expenditures in EU countries and found that health care expenditures are converging upwards towards the EU mean. 
Sab and Smith (2001) analyzed human capital convergence, using the enrollment rates and life expectancy. 
According to their paper, “the improvement in health is more critical to successful improvement in education, than is 
the improvement of education to successful improvement in health” (ibid, p.21). 
  
The rest of the paper is structured as follows. In section 2, we analyze health care expenditure as per cent of 
GDP and per capita health care expenditure in EU-15 and in EU-12 member states. Section 3 describes the 
theoretical approaches of the evaluation methods of convergence used in this research.  Section 4 shows empirical 
results of convergence in health care expenditure and the last section concludes the paper. We have used the WHO 
database. The sample covers the period of 1992-2004. The countries under study are EU member states included EU 
new member states for which the data are available (Czech Republic, Estonia, Hungary, Latvia, Lithuania, Poland, 
Slovakia, Slovenia).  
 
2.  HEALTH AND HEALTH CARE EXPENDITURE: COMPARATIVE ANALYSIS 
 
Among the indicators characterizing a population’s health, one of the most often used ones internationally is 
life expectancy at birth. Comparing the life expectancy at birth in EU-12 countries and in EU-15 countries we can see 
that in EU-15 the life expectancy at birth is higher than in EU-12 countries (see Figure 1).  
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Figure 1:  Females and males life expectancy at birth in 2004 
 
 
Although in 1991-2004 the life expectancy rose both in EU-15 countries and EU-12 countries, the 
differences in the life expectancy have still remained more or less the same. The life expectancy in EU-15 was 75.29 
years in 1991 and 78.27 in 2004; the respective indices in EU-12 were 70.73 and 73.91. 
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If to compare the Baltic states to EU-15, we can see that the life expectancy in the Baltic states is lower. 
Sharp economic changes in the Baltic states caused an essential decline in the life expectancy in the transition 
period. Figure 2 demonstrates that the life expectancy fall that started in 1991 achieved its lowest in 1994, whereas 
the in Estonia and Latvia the decline was bigger than in Lithuania. By 1997, the Baltic states achieved the life 
expectancy level that was before the beginning of the decline. From then on the life expectancy has been rising and 
the difference from EU-15 has diminished slightly (see Figure 2) 
 
The difference between male and female life expectancy in EU-15 countries was approximately 6 years in 
2004, but in EU-12 countries it was much bigger (approximately 10 years)(see Figure 1). This difference is 
especially large in Estonia and Lithuania (approximately 11 years).  The male life expectancy in the Baltic states is 
approximately 10 years shorter than in the average for EU-15.  
 
Life expectancy has increased in all EU Member States excluding Baltic countries. For example, in Estonia 
the life expectancy has increased 2.88 years for men and 3.24 years for women over the same period (WHO 
database). The only exception is Latvia where the male life expectancy rose only 0.25 years over the period 1991-
2004. As noted before, life expectancy in the Baltic countries is especially low among men. A problem in the Baltic 
countries is early mortality ─ that is deaths before 65 years of age, which make up nearly one third of all deaths. The 
major explanatory factor is psychological stress associated with turbulent times, with rising unemployment, poverty, 
and alcohol consumption (Brainerd et al.1998).  
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Figure 2:  Life expectancy at birth in Baltic countries and in EU-15 in 1991-2005 
 
 
Besides the low life expectancy in EU new member states, also the resources used in health care sector are 
below the EU average level. In 2004, the average EU-15 expenditure on health care was 9.43% of the GDP, which 
are approximately 3 percentage points higher than in EU-10 (see Table 1). 
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Table 1:  Total health care expenditure as percentage of GDP and PPP$ per capita 
 
Country Total health care expenditure as % 
of GDP 
Country Total health care expenditure, PPP$ 
per capita 
Relative order based 
on data of 2004 
1992 2004 Change 
1992-2004 
(%points) 
Relative order 
based on data of 
2004 
1992 2004 Change 
1992s (%) 
Germany 9.7 10.7 1.0 Luxembourg 1758 5089 289.5 
France 8.9 10.5 1.6 France 1752 3159 180.3 
Portugal 7 10 3.0 Belgium 1557 3145 201.9 
Greece 7.9 9.8 1.9 Austria 1541 3124 202.7 
Belgium 7.7 9.8 2.1 Germany 1961 3056 155.8 
Austria 7.4 9.6 2.2 Netherlands 1632 3041 186.3 
Sweden 8.3 9.3 1.0 Denmark 1641 2881 175.6 
Denmark 8.3 8.9 1.6 Sweden 1604 2825 176.1 
Netherlands 8.1 8.9 0.8 Ireland 1007 2596 257.8 
Italy 8 8.7 0.7 United Kingdom 1181 2546 215.6 
Slovenia 7.4 8.6 1.2 Italy 1550 2392 154.3 
United Kingdom 6.9 8.3 1.4 Finland 1552 2235 144.0 
Hungary 7.6 8.3 0.7 Greece 963 2162 224.5 
Spain 7.1 8.1 1.0 Spain 1030 2094 203.3 
Luxemburg 5.4 7.7 2.2 Portugal 852 1813 212.8 
Finland 9 7.5 -1.5 Slovenia 448.5 1801 401.6 
Czech Republic 5.1 7.3 2.2 Czech Republic 570 1361 238.8 
Ireland 7 7.1 0.1 Hungary 633 1323 209.0 
Poland 6.2 6.5 0.3 Poland 378 805 213.0 
Cyprus 4.6 6.3 1.7 Lithuania 155.4 786.4 506.0 
Latvia 2.8 6.3 3.5 Estonia 301.1 771.4 256.2 
Lithuania 4.2 6 1.8 Latvia 169.7 734.1 432.6 
Estonia 4.5 5.3 0.8 EU-12 353.7 782.8 221.3 
EU-12 5.32 6.01 0.69 EU-15 1524 2694 176.8 
EU-15 8.21 9.43 1.22     
Source: WHO database 
 
 
The corresponding ratio at the same time was more than 3 percentage points lower in Latvia and in 
Lithuania. The ratio was the lowest in Estonia (5.3%), which positioned Estonia the last, among 23 countries (see 
Table 1). From the new member states in Slovenia the health care expenditure as percentage of GDP comes closest 
to the EU-15 average. The highest health care expenditure in 2004 was in Germany (10.7% of GDP).  
 
Despite that the share of health care expenditure in GDP in the period 1992-2004 increased in all EU 
member states (with the exception of Finland), the growth in EU old member states was faster than in new member 
states (Figure 3). 
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Figure 3:  Health care expenditure as share of GDP 
 
 
The per capita health care expenditure in EU-15, on average (based on PPP$), was 1524$ in 1992 and 
2694$ in 2004. During the period 1992-2004, the per capita health care expenditure increased in all of the EU 
countries (see Figure 4). Figure 4 depicts that per capita health care expenditure in the period 1992-2004 increased 
in EU-15 much faster than in EU-12. 
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Figure 4:  Per capita health care expenditure 
 
 
The biggest growth of per capita health care expenditure in the period 1992-2004 was in Latvia, the 
smallest in Finland (see Table 1). Comparing the shares of health care expenditure in GDP and health care 
expenditure per capita, we can see that the relative order of countries based on data of 2004 has changed. The first 
position by the share of health care expenditure in GDP was occupied by Germany, but Luxembourg had the leading 
position by per capita health care expenditure. At the same time, the Baltic states close the ranking lists in both 
indicators.  
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The highest per capita health care expenditure was in Luxembourg − 189% of the EU-15 average in 2004. 
Among the new member states, Slovenia had the biggest per capita health care expenditure − 67% of the average 
EU-15 level (see Figure 5) 
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Figure 5:  Health care expenditure in 2004 in % compared to EU-15 (EU-15 =100) 
 
 
At the same time, per capita health care expenditure in Estonia was 28.6%, in Latvia 27% and Lithuania 
29% of the EU-15 average level. The above analysis demonstrated that life expectancy in EU new member states is 
much lower than in old ones. The situation of health care expenditure is similar, both per capita expenditure and as 
percentage of GDP. 
 
3.  METHODS FOR EVALUATING CONVERGENCE 
 
According to the economic theory of convergence, economic development level of less developed countries 
should approach the level of more advanced countries which have the same economic resources or fundamentals. 
Socio-economic convergence is mainly discussed in the context and on the basis of two main economic growth 
theories: neo-classical and endogenous. Two main concepts of convergence are used in the classical literature of 
growth theory: σ-convergence -convergence -i-Martin, 1996).  
 
One of the simplest methods for estimating socio-economic convergence is to calculate σ-convergence on 
the basis of standard deviation. With this method it is possible to examine how the dispersion between national 
income levels (or other indicators) has changed, or how the differences of indicators inside groups of countries are 
changing compared to the average (Dorwick and Nguyen, 1989; Barro and Sala-i-Martin, 1992). A reduction 
coefficient of variance (standard deviation/arithmetic mean) of indicators indicates a reduction of the difference, or 
the presence of σ-convergence. 
  
The test for the presence of -convergence (DeLong, 1988; Barro and Sala-i-Martin, 1991, 1992; Sala-i-
Martin, 1994; Boyle and McCarthy, 1997) posits that -convergence exists if a poor economy tends to grow at a 
faster rate than a rich one so that the poor country tends to catch up in terms of per capita income or product. The 
literature makes distinction between absolute (unconditional) and conditional -convergence. Absolute -
convergence pertains to the coefficient  of the bivariate equation. This is based on the assumption that all countries 
in the sample converge to the same steady state. 
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We used the following equation to estimate absolute-convergence: 
ii
i
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, (1) 
 
where the left-hand side is the average annual growth rate of the health care expenditure in country i at time T. α is a 
constant term, εi- the error term. The condition for -convergence is the test that β < 0. 
 
For the assessment of the speed of convergence we used the following equation: 
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where b is the rate of convergence. 
 
Conditional -convergence pertains to the coefficient  of the socio-economic level variable in an equation 
that includes additional explanatory variables reflecting differences across countries, which direct each economy to 
converge to its own steady state. In both cases, the convergence hypothesis is that the growth rate of a socio-
economic indicator will be negatively related to the level of this indicator. 
 
Boyle and McCarthy proposed a simple but unbiased measure of convergence that is consistent with Sala-i-
Martin (1994) concept of β-convergence. Motivation for the measurement is Sala-i-Martin`s (1994) interpretation of 
β-convergence, which is concerned with tracking the mobility of individual countries within the distribution of 
income levels over time. Taking this interpretation as given, a straightforward and direct assessment of inter-
temporal mobility would require an examination of the change in the ranking of income levels. A simple measure 
that captures the change in rankings is Kendall’s index of rank concordance (Boyle and McCarthy, 1997) 
 
In the context of measuring β-convergence Kendall’s index could be computed in a number of ways. First, 
one could generate a multi-annual version (RCt) of the index, which takes account of the ranks for intervening years 
between t and 0 by computing the index for a moving-sum of years: 
 
 
    0
0
1 i
T
t
it
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
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where AR(Y)it – the actual rank of country i’s income level (per capita) in year t; AR(Y)i0 – the actual rank of country 
i’s income level (per capita) in the initial year 0; T+1 – the number of years for which data are used for constructing 
the index. Alternatively, one could obtain a binary version (RCat) by focusing on the concordance between the ranks 
in year t and year 0: 
 
    
  0
0
2 i
iit
t
YARVariance
YARYARVariance
RCa


  (4) 
 
The multi-annual index contains all possible pairs of years for which the binary measure could be computed 
(γ-convergence). 
 
The value of our rank concordance index ranges from zero to unity. The denominator of the index is the 
maximum sum of ranks, which would be obtained if there were no change in rankings over time. The closer the 
index value is to zero, the greater the extent of mobility within the distribution. This index is in the spirit of the 
coefficient of variation measure of σ-convergence when the latter is converted to a 0.1 index by simply dividing 
each year’s coefficient by the initial year’s value. Kendall’s original rationale for the rank concordance measure was 
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a solution to the problem of ascertaining the overall agreement among k sets of rankings. It is therefore ideally suited 
to testing for the presence of β-convergence (Boyle and McCarthy, 1999: p.8). 
 
4.  EMPIRICAL ANALYSIS 
 
4.1.  -convergence 
 
For testing absolute -convergence we used two measures of health care expenditure: health care 
expenditure as a share of real GDP and per capita health care expenditure at PPP$. Following Sala-i-Martin (1996), 
we used a log linear regression to estimate the annual growth rate of the expenditure share based on the initial level 
of the share at the beginning of the period. If the slope coefficient is negative, we say that there exists absolute 
convergence in health care expenditure as a share of real GDP and per capita (Tables 2, 3). 
 
Regarding absolute -convergence, Table 3 shows that the coefficient  for health care expenditure as a 
share of real GDP is negative and statistically significant for EU-23 countries. The value of   is -0.040 and 95% 
confidence interval -0.055 <   < -0.025. Our results satisfy the  conditions for convergence in health care 
expenditure as a share of real GDP across EU-23 countries and also for EU-8.The value of   is -0.054 and 95% 
confidence interval -0.080 <  < -0.028 (see Table 2 and Figure 6). As we have verified in our previous studies 
(Püss et al., 2003), -convergence can be identified also in health care expenditure as a share of real GDP across 
EU-15 countries.  
 
 
Table 2:  Absolute -convergence in health care expenditure in 1992-2004, as a share of GDP (%) 
 
 Coef. StdErr T P>t [95% CI] 
EU-23       
Β -0.040 0.008 -5.250 0.000 -0.055 -0.025 
Α 0.092 0.015 6.270 0.000 0.063 0.121 
R2 0.57      
Annual convergence rate (%) 5.5 1.7 3.1 0.005 2.1 8.9 
Thalf (in years) 13 3   7 19 
EU-15       
Β -0.052 0.018 -2.930 0.012 -0.087 -0.017 
Α 0.119 0.037 3.260 0.006 0.048 0.191 
R2 0.40      
Annual convergence rate (%) 8.3 3.3 2.5 0.028 1.7 14.8 
Thalf (in years) 8 2   4 13 
EU-8       
Β -0.054 0.013 -4.124 0.006 -0.080 -0.028 
Α 0.111 0.022 5.077 0.002 0.068 0.153 
R2 0.74      
Annual convergence rate (%) 8.7 3.5 2.5 0.049 1.8 15.7 
Thalf (in years) 8 2   3 12 
 
 
Figure 6 demonstrates that there has been -convergence in health care expenditure as a share of GDP. The 
figure displays the convergence hypothesis since a higher initial health care expenditure level is associated with 
lower growth rate in the level over the period. 
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Figure 6:  Absolute -convergence in health care expenditure in 1992-2004, as a share of GDP (%) 
 
 
According to the equation (2), the rate of convergence (b) shows a rather high speed of convergence. The 
estimated average annual convergence rates are 5.5% in EU-23, 8.3% in EU-15 and 8.7% in EU-8. Starting from 
1992, it takes about 10 years for one half of the differences in health care expenditure (as a share in GDP) between 
EU-8 countries and EU-15 average to disappear at the 7% annual rate of convergence. 
 
 
Table 3:  Absolute -convergence in health care expenditure in 1992-2004, annual growth rate per capita at PPP$ 
 
  Coef. StdErr T P>t [95% CI] 
EU-23       
Β -0.027 0.005 -5.180 0.000 -0.037 -0.016 
Α 0.246 0.035 7.064 0.000 0.173 0.318 
R
2
 0.56      
Annual convergence rate (%) 3.2 0.7 4.7 0.000 1.9 4.5 
Thalf (in years) 22 4   14 29 
EU-15       
β -0.027 0.015 -1.790 0.097 -0.600 0.006 
α 0.252 0.110 2.300 0.039 0.015 0.488 
R
2
 0.20      
Annual convergence rate (%) 3.3 1.8 1.8 0.1 -0.3 6.9 
Thalf (in years) 21 8   6 36 
EU-8       
β -0.047 0.017 -2.850 0.029 -0.088 -0.007 
α 0.365 0.098 3.730 0.010 0.125 0.604 
R
2
 0.58      
Annual convergence rate (%) 7.0 1.6 4.3 0.000 3.8 10.2 
Thalf (in years) 10 2   6 14 
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Table 3 shows that analogously with health care expenditure as a share of GDP the coefficient of   for 
per capita health care expenditure was negative and statistically significant for all groups of EU countries in the 
period 1992-2004. For EU-23 countries are the values:   -0.027 and 95% confidence interval -0.037 <  < -0.016. 
There are two main outliers, Slovenia and Luxembourg, where the initial level of health care expenditure was higher 
and the growth faster compared with EU-8 and EU-15 countries’ average, respectively. Without these two countries 
the  coefficient won’t change notably for EU-23, but would have fallen to the level -0.038 in EU-15 and -0.053 in 
EU-8 and would have been statistically more reliable. The presence of absolute -convergence (<0) for all groups 
of countries indicates dependence of growth on the initial level of the indicator. On the whole, our results satisfy the 
conditions for convergence in health care expenditure per capita across EU countries over the period 1992-2004. 
 
Figure 7 illustrates the health care expenditure per capita at PPP convergence across EU-23 countries in the 
period 1992-2004. The initial level is on the horizontal axis and the annual rate of growth on vertical axis. 
According to the definition of absolute -convergence, for convergence to exist the regression line must be 
downward sloping.  
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Figure 7:  Absolute -convergence in health care expenditure in 1992-2004, per capita at PPP$ 
 
 
4.2.  σ- and γ- convergence 
 
We evaluate σ-convergence in EU-23 countries and independently in EU-15 countries and EU-8 countries, 
using the total health care expenditure as % of GDP and per capita at PPP$. The tested variation coefficient for EU-
23 countries fell from 0.247 to 0.186 (Figure 8) and from 0.546 to 0.490 (Figure 9) respectively, conforming that the 
health care expenditures have converged in the period 1992-2004. This is also evidenced by the increased ratio of 
the minimum to maximum of both indicators: for health care expenditures as % of GDP from 29% to 50% and for 
health expenditure per capita from 8% to 14%. The country with the highest health care expenditure per capita at the 
beginning of the period was Germany, but since 1999 it has been Luxembourg, and its lead before other countries 
has progressively increased from year to year. The health care expenditure was the lowest throughout the period in 
Latvia.   
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Figure 8:  Coefficients of variation of health care expenditure as a share of GDP 
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Figure 9:  Coefficients of variation of health care expenditure per capita at PPP$ 
 
In EU-15 countries we can observe the divergence of health care expenditure as a share of GDP in the 
period 1992–2000 (the coefficient of variation increased from 0.134 to 0.163) and convergence in the period 2000-
2004 (the coefficient of variation fell from 0.163 to 0.119) (Figure 8). Exactly the opposite is the situation in health 
care expenditure per capita. In the period 1992-2001, the variation coefficient fell from 0.236 to 0.202 and in the 
period 2001-2004 rose from 0.202 to 0.272 (Figure 9). Analyzing the changes in countries we can see that an 
extraordinarily fast growth of per capita expenditure in Luxembourg is a factor that led to divergence at the end of 
the period. The increase in the per capita health care expenditure has been induced in addition to a fast economic 
growth in Luxembourg, where the development level is very high, by an increasing pendulum migration in recent 
years. According to the health care organization in Luxembourg, all citizens of the neighboring countries who work 
in Luxembourg (about 25% of Luxembourg’s insured workers) are covered by health insurance, while  per capita 
expenditure calculations are based on the resident population.  σ-convergence calculations without Luxembourg 
confirm the influence of this country on the presence of divergence in recent years. 
 
In the EU-8 countries the coefficient of variation of per capita health care expenditure decreased from 0.446 
in 1992 to 0.377 in 2004. However, the beginning of the period was characterized rather by a divergence, but since 
1996 the differences between countries have diminished (increased only in 2000). In health expenditure as a share of 
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GDP the variation coefficient decreased until 1999 from 0.306 to 0.131. From 1999 to 2003 we had a divergence 
period. In EU-8 countries the ratio of minimum to maximum expenditure has improved, both per capita and as a 
share of GDP. At the same time, changes have occurred in countries with the minimal and maximal level. Early in 
the period, the lowest level of the indicators was in Latvia and the highest in Hungary, but by the end of the period 
Slovenia achieved the maximum level and Estonia had fallen to the minimum level by the share of expenditure in 
GDP. 
 
As we know from the theory, σ-convergence is sufficient for β-convergence. In the periods when σ is more 
or less stable, the β-convergence exists when substantial γ-convergence takes place. In addition to testing for β-
convergence, the Kendall’s rank concordance index (γ- convergence) enables to estimate changes in the country’s 
ranking. A binary indicator measures the importance of changes compared to the base period, while multi-annual 
index measures changes taken place during the whole test period. 
 
Tables 4–6 present the coefficient of variance that characterizes changes of σ-convergence compared to the 
first year of survey (columns 2 and 5). The measures of β-convergence, based on the multi-annual Kendall’s rank 
concordance index, are presented in columns 3 and 6 and the Binary-Kendall version in columns 4 and 7. 
 
Based on the analysis of σ- convergence we can affirm that health care expenditures (% of GDP) in EU-15 
have diverged in the period 1992-2000 and converged in the period 2001-2004. Calculated for the whole period, the 
average speed of σ- convergence was 1.04% per year (Table 4) and the average speed of γ-convergence, based on 
Kendall’s binary and multi-annual indices, was 2.04% and 2.16% per year. There were statistically significant 
differences in individual country rankings (p<0.05) compared to the base period until 2000, after that the process 
stabilized. Between 1992 and 2004, the countries in a lowest position like Portugal (+7), Austria and Greece (+6), 
improved their position the most and the biggest fall from the initially high position occurred in Finland (-8) and 
Denmark (-6). 
 
 
Table 4:  Sigma and Gamma Convergence in EU-15, 1992-2004 
 
 
Total health expenditure, % GDP Total health expenditure, PPP$ per capita 
σ-convergence 
Multi-annual 
Kendall 
Binary-
Kendall σ-convergence 
Multi-annual 
Kendall Binary-Kendall 
1992 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 
1993 0.9830 0.9857 0.9857 0.9757 0.9893 0.9893 
1994 1.0999 0.9857 0.9875 0.9509 0.9762 0.9750 
1995 1.1727 0.9585 0.9661 0.9902 0.9652 0.9643 
1996 1.1904 0.9300 0.9321 0.9836 0.9546 0.9429 
1997 1.1885 0.8482 0.7821 0.8994 0.9280 0.8875 
1998 1.2202 0.8118 0.7804 0.9085 0.9173 0.8875 
1999 1.2003 0.7915 0.7732 0.9213 0.9145 0.8893 
2000 1.2081 0.7797 0.7571 0.8793 0.9151 0.8911 
2001 1.1328 0.7766 0.7571 0.8558 0.9171 0.9054 
2002 1.0426 0.7740 0.7357 0.8931 0.9136 0.8732 
2003 0.9768 0.7754 0.7357 1.0929 0.9131 0.8696 
2004 0.8823 0.7812 0.7696 1.1517 0.9120 0.8679 
Γ, % -1.04 -2.04 -2.16 1.18 -0.76 -1.17 
 
 
Table 4 also characterizes changes in health care expenditure (as PPP$). In EU-15, σ-divergence has taken 
place, on average 1.18% per year. Together with growing differences, major changes in country rankings had taken 
place until 1997, and then the process stabilized. By multi- and binary methods, the speed of γ-convergence was 
0.76% and 1.17% per year. The biggest changes compared to 1992 have been in Austria (+6) − forward, and in 
Sweden (- 6) − backward.  
 
International Business & Economics Research Journal – March 2008 Volume 7, Number 3 
41 
Contrary to the EU-15 countries, a fast σ-convergence in health care expenditures as % of GDP took place 
in EU-8 group in 1992 -1999 (Table 5). In 2000, the indicators started to diverge again.  The average annual speed 
was 4.5%. Parallel to σ-convergence, also γ-convergence took place, lasting until the last year of the test period.  
 
 
Table 5:  Sigma and Gamma Convergence in the EU- 8, 1992-2004 
 
 
Total health expenditure, % GDP Total health expenditure, PPP$ per capita 
σ-convergence 
Multi-annual 
Kendall 
Binary-
Kendall σ-convergence 
Multi-annual 
Kendall 
Binary-
Kendall 
1992 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 
1993 0.8618 0.9405 0.9762 1.3626 0.9762 0.9762 
1994 0.8128 0.9259 1.0000 1.2777 0.9418 0.9286 
1995 0.7135 0.9286 0.9762 1.4178 0.9286 0.9048 
1996 0.5496 0.9352 0.9762 1.2923 0.9295 0.9048 
1997 0.5154 0.9153 0.9405 1.2509 0.9339 0.9048 
1998 0.5920 0.8989 0.9405 1.0434 0.9388 0.9048 
1999 0.4298 0.9010 0.9762 1.0121 0.9435 0.9048 
2000 0.5561 0.8889 0.9048 1.0788 0.9477 0.9048 
2001 0.6227 0.8733 0.8690 1.0386 0.9467 0.8810 
2002 0.7105 0.8650 0.8690 1.0135 0.9425 0.8571 
2003 0.7169 0.8677 0.9048 0.9570 0.9464 0.9048 
2004 0.5703 0.8518 0.8333 0.8451 0.9467 0.8810 
Γ, % -4.572 -1.328 -1.508 -1.39 -0.46 -1.05 
 
 
In EU-8 countries (PPP$ per capita), the country differences had decreased by 2004, compared to 1992 
(Table 5), despite the divergence at the beginning of the test period when the variation coefficient increased by 12% 
a year. The Kendall’s index declined at the beginning of the test period, indicating changes in the country ranking. 
Hungary, which initially was in the leading position, declined to the third position and Slovenia occupied the leading 
position in 1995 and has retained it among EU-8 countries until today. But changes in the country rankings were not 
statistically significant (p<0.05). In the following years, σ declined until 1998-1999 and stabilized after that. 
Changes in the period 2002-2004 changed σ < 1, and the average annual speed of the whole period was 1.39%. 
Kendall’s indexes were more or less stable, indicating absence of γ-convergence. The highest indicator was in 
Slovenia and Czech Republic, the lowest in Latvia and Lithuania. Estonia has remained on the sixth-seventh 
position throughout the test period. From the non-existence of γ we can conclude that β-convergence occurred only 
in 1996-2004 (an exception was 2000), together with σ-convergence. 
 
Computing the σ index analogously with the variation coefficient, but using EU-15 average instead of EU-8 
average, we get an indicator that describes changes in EU-8 compared to EU-15 average. During the whole period, 
differences have declined, on average 1.33% per year. According to this calculation, the convergence of EU-8 to the 
level of EU-15 would take approximately 23 years. 
 
Analyzing all EU-23 members together (Table 6), we can perceive σ-convergence during the whole period 
(total health expenditure, PPP$ per capita) − on average 0.90% per year and as % of GDP − 2.34 per year. 
Consequently, the β-convergence has also taken place. Kendall’s indicators remained stable, changing on average 
0.2-0.3% per year. During the convergence period (PPP$ per capita) there were very few changes in country ratings. 
Not one new member could surpass any EU-15 country and changes in the rankings took place only within country 
groups.  
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Table 6:  Sigma and Gamma Convergence in the EU- 23, 1992-2004 
 
 
Total health expenditure, % GDP Total health expenditure, PPP$ per capita 
σ-convergence 
Multi-annual 
Kendall 
Binary-
Kendall σ-convergence 
Multi-annual 
Kendall 
Binary-
Kendall 
1992 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 
1993 0.9054 0.9827 0.9827 0.9984 0.9931 0.9931 
1994 0.8555 0.9583 0.9491 0.9593 0.9910 0.9891 
1995 0.8900 0.9211 0.8918 0.9697 0.9836 0.9743 
1996 0.8322 0.9122 0.8943 0.9436 0.9822 0.9743 
1997 0.8056 0.9087 0.8809 0.9275 0.9826 0.9753 
1998 0.8267 0.9083 0.8720 0.8993 0.9836 0.9758 
1999 0.7785 0.9111 0.8725 0.8994 0.9843 0.9783 
2000 0.8452 0.9114 0.8631 0.8959 0.9833 0.9718 
2001 0.8615 0.9124 0.8622 0.8909 0.9831 0.9718 
2002 0.8458 0.9144 0.8701 0.8702 0.9825 0.9718 
2003 0.8398 0.9149 0.8710 0.9073 0.9795 0.9654 
2004 0.7525 0.9151 0.8725 0.8973 0.9777 0.9639 
Γ, % -2.34 -0.74 -1.13 -0.90 -0.19 -0.31 
 
 
Based on the σ-convergence index that was calculated on the basis of EU-15 average, the EU-8 differences 
declined until 1994, after that the process stabilized and since 1999 a divergence can be seen. The same trend can be 
perceived while analyzing EU-23 together. Both σ- and γ-convergence took place until 1994 and after a stabilization 
period, the differences increased again. 
 
CONCLUSIONS 
 
In this paper we examined the convergence of health care expenditure in EU countries. For testing β-, σ- 
and γ-convergence we used cross-sectional data over the period 1992-2004 for health care expenditure as share of 
GDP and per capita. The results of the analysis indicate that there has been β-convergence in health care 
expenditure as a share of GDP. The rate of convergence shows a rather high speed of convergence: starting from 
1992, it takes about 10 years for one half of the differences in health care expenditure (as a share in GDP) between 
EU-8 countries and EU-15 average to disappear at the 7% annual rate of convergence. 
 
The test for σ-convergence in EU-23 countries, independently in EU-15 and EU-8 countries, confirmed that 
the health care expenditures have converged in the period 1992-2004. The annual average speed of σ- convergence 
was 1.04% and the average speed of γ-convergence, based on Kendall’s binary and multi-annual indices, was 2.04% 
and 2.16% in EU-15. There were statistically significant differences in individual country rankings compared to the 
base period until 2000, after that the process stabilized (between 1992 and 2004, the countries in the lowest position 
like Portugal, Austria and Greece, improved their position the most and the biggest fall from the initially high 
position occurred in Finland and Denmark). In EU-8 group the average annual speed of convergence was 4.5%. For 
all EU-23 countries, we can perceive σ-convergence during the whole period by an average of 0.90% annually; β-
convergence has also taken place and Kendall’s indicators remained stable, changing on average by 0.2-0.3% per 
year (there were very few changes in country ratings, not one EU-10 member state could surpass any EU-15 country 
and changes in the rankings took place only within country groups).  
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